Example ImageÃÀ¸ß÷

EN
EN
  • ÓªÒµ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÓªÒµ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞЧÀÍ×Éѯ£¬£¬£¬£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
News information
ÐÂÎÅ×ÊѶ

͸¹ýÒ»¿Å²¼Âå·Ò£¬£¬£¬£¬Ãé×¼»¯Ñ§ºÏ³É£¡

2023-01-02
|
»á¼ûÁ¿£º

×î½üҽҩȦ×î»ðµÄ¶¥Á÷µ±Êô»ÔÈðйÚÌØÐ§Ò©ÅÁÂÞΤµÂ(Paxlovid)ºÍ¹úÃñÉñÒ©²¼Âå·Ò(Ibuprofen)¡£¡£¡£¡£¡£¡£Ö®Ç°ÎÒÃÇÏêϸ¸ø¸÷È˽éÉܹý¡°Í¨Íù¿¹Ð¹ڵÄÌØÐ§º½µÀ¡ª¡ªÅÁÂÞΤµÂ¡±£¨µã»÷Ïàʶ£©¡£¡£¡£¡£¡£¡£½ñÌìÎÒÃÇÀ´ÁÄÁIJ¼Âå·ÒÕâ볤ÇàÒ©µÄºÏ³ÉºÍ×÷ÓûúÖÆ£¡½üÆÚµÄ²¼Âå·ÒÄÇ¿ÉνÊÇÒ»Á£ÄÑÇ󣬣¬£¬£¬Ò»Ô¾³ÉΪÏìµ±µ±µÄӲͨ»õ¡£¡£¡£¡£¡£¡£

²¼Âå·Ò

²¼Âå·Ò£¬£¬£¬£¬·Ö×ÓʽC13H18O2£¬£¬£¬£¬»¯Ñ§ÃûΪ2-(4-Isobutylphenyl)propanoic acid¡£¡£¡£¡£¡£¡£²¼Âå·ÒÊÇÒ»ÖÖ³£ÓõķÇçÞÌåÀ࿹Ñ×Ò© (NSAID)£¬£¬£¬£¬Í¨¹ýÒÖÖÆ»·Ñõ»¯Ã¸£¬£¬£¬£¬ïÔ̭ǰÏßÏÙËØµÄºÏ³É£¬£¬£¬£¬±¬·¢ÕòÍ´¡¢¿¹Ñ××÷Ó㻣»£»£» £»Í¨¹ýÏÂÇðÄÔÌåε÷ÀíÖÐÊà¶øÆð½âÈÈ×÷Óᣡ£¡£¡£¡£¡£²¼Âå·Òͨ³£ÄÍÊÜÐÔÓÅÒ죬£¬£¬£¬Ò»Ñùƽ³£²»»áÒýÆðÁÙ´²ÉÏÏÔ×ŵÄÑÏÖØ¼±ÐÔ¸ÎËðÉË¡£¡£¡£¡£¡£¡£

1-²¼Âå·Ò»¯Ñ§½á¹¹.jpg

²¼Âå·Ò»¯Ñ§½á¹¹

²¼Âå·Ò˳Ӧ֢

¿Ú·þ¸øÒ©£ºÓÃÓÚ¼õÇáÇá¶ÈÖÁÖжÈÌÛÍ´£¬£¬£¬£¬ÈçÊàŦʹ£¬£¬£¬£¬Éñ¾­Í´£¬£¬£¬£¬¼¡ÈâÍ´£¬£¬£¬£¬Æ«Í·Í´£¬£¬£¬£¬Í·Í´£¬£¬£¬£¬Í´¾­£¬£¬£¬£¬ÑÀÍ´£¬£¬£¬£¬Ò²¿ÉÓÃÓÚ¼õÇáͨË×ÉË·ç»òÊ¢ÐÐÐÔÉË·çÒýÆðµÄ·¢ÈÈ¡£¡£¡£¡£¡£¡£

×¢Éä¸øÒ©£ºÓÃÓÚ½âÈȺÍÕòÍ´ÖÎÁÆ£ºÖÎÁÆÇáÖÁÖжÈÌÛÍ´£¬£¬£¬£¬×÷Ϊ°¢Æ¬ÀàÕòÍ´Ò©µÄ¸¨ÖúÓÃÓÚÖÎÁÆÖÐÖÁÖØ¶ÈÌÛÍ´£»£»£»£» £»·¢ÈȵÄÍËÈÈÖÎÁÆ¡£¡£¡£¡£¡£¡£

²¼Âå·Ò×÷ÓûúÖÆ

²¼Âå·ÒÊÇÒ»ÖַǶÔÓ³Òì¹¹µÄÊÖÐÔÒ©Î£¬£¬£¬°üÀ¨R-²¼Âå·ÒºÍS-²¼Âå·Ò¡£¡£¡£¡£¡£¡£Ò©´ú¶¯Á¦Ñ§Ñо¿Åú×¢Ò©ÎïµÄ´ó²¿·ÖÒ©Àí»îÐÔÐÎʽÊÇÓÉÆä S-¶ÔÓ³ÌåТ˳µÄ£¬£¬£¬£¬ÓÉÓÚËü»áÒÖÖÆÇ°ÏßÏÙËØµÄºÏ³É¡£¡£¡£¡£¡£¡£ÔÚ 20 ÊÀ¼Í 70 ÄêÔ³õÆÚÖÁÖÐÆÚ£¬£¬£¬£¬Ê״ᨵÀÁËÎÞ»îÐÔ R-¶ÔÓ³Òì¹¹Ìåͨ¹ýµ¥Ïòø´Ùת»¯Îª»îÐÔS-¶ÔÓ³Òì¹¹Ìå¡£¡£¡£¡£¡£¡£Ô¼Äª 40-60% µÄR-¶ÔÓ³Òì¹¹ÌåÔÚ¸ÎÔàÖдúлΪS-²¼Âå·ÒÐÎʽ¡£¡£¡£¡£¡£¡£Æä¿¹Ñ××÷ÓÃÊÇÓÉÓÚS-²¼Âå·Ò¶Ô»·ÑõºÏø (COX) ¾ßÓÐÒÖÖÆ»îÐÔ£¬£¬£¬£¬COXÈÏÕæÇ°ÏßÏÙËØµÄºÏ³É£¬£¬£¬£¬²¢ÔÚÑ×Ö¢·´Ó¦¼Ó¾ç½éµ¼µÄÉñ¾­ÔªéæÃüÖÐʩչÖ÷Òª×÷Óᣡ£¡£¡£¡£¡£²¼Âå·ÒÒÖÖÆ COX£¬£¬£¬£¬ïÔÌ­Ò»Ñõ»¯µª (NO) µÄ±¬·¢²¢¼¤»î¹ýÑõ»¯ÎïøÌåÔöÖ³ÎD»îÊÜÌå-¦Ã (PPAR-¦Ã)¡£¡£¡£¡£¡£¡£

2-²¼Âå·Ò×÷ÓûúÖÆ.jpg

²¼Âå·Ò×÷ÓûúÖÆ[1]

²¼Âå·Ò»¯Ñ§ºÏ³É

²¼Âå·ÒÓÚ 1961 ÄêÓÉ Boots Pure Chemical Company Ê״λñµÃרÀû£¬£¬£¬£¬²¢ÓÚ 1984 Äê±»Åú׼Ϊ·Ç´¦·½Ò©¡£¡£¡£¡£¡£¡£×ÔÎÊÊÀÒÔÀ´£¬£¬£¬£¬²¼Âå·ÒÒ»Ö±ÒÔ Advil? ºÍ Motrin? µÈ¶à¸öÆ·ÅÆÏúÊÛ¡£¡£¡£¡£¡£¡£²¼Âå·ÒµÄºÏ³ÉÊÇ´ÓÒì¶¡»ù±½×îÏȵÄ¡£¡£¡£¡£¡£¡£ºÏ³ÉÀú³Ì°üÀ¨ Friedel-Crafts õ£»£»£»£» £»ù»¯¡¢»¹Ô­¡¢ÂÈ»¯ÎïÈ¡´úºÍ Grignard ·´Ó¦¡£¡£¡£¡£¡£¡£ È»ºóͨ¹ý IR ºÍ 1 H NMR ¹âÆ×ÆÊÎöÿ¸ö°ì·¨µÄ²úÆ·£¬£¬£¬£¬²¢Í¨¹ýÈÛµãµÄ²â¶¨ÆÊÎöÈ·ÈÏ×îÖÕ²úÆ·¡£¡£¡£¡£¡£¡£

1992 Ä꣬£¬£¬£¬BHC ¹«Ë¾¿ª·¢ÁËÒ»ÖÖеĿÉÒ»Á¬ºÏ³ÉÒªÁ죬£¬£¬£¬½«ºÏ³É°ì·¨¼õ°ë¡£¡£¡£¡£¡£¡£µÚÒ»²½Ê¹ÓÃÎÞË®·ú»¯Çâ×÷Ϊ´ß»¯¼ÁºÍÈܼÁ£¬£¬£¬£¬È»ºó½«Æä½ÓÄÉÔÙʹÓᣡ£¡£¡£¡£¡£±ðµÄ£¬£¬£¬£¬BHC ÒªÁì±³ºóµÄÕæÕýÁÁµãÔÚÓÚ½µµÍÁ˲»ÐèÒªµÄ·ÏÎïºÍÔÓÖÊ£¬£¬£¬£¬Ö»±¬·¢Ò»¸öË®·Ö×Ó×÷Ϊ¸±²úÆ·£¬£¬£¬£¬ÕýÊÇÕâÒ»µã´Ù³ÉÁËÕæÕýµÄÂÌÉ«ºÏ³É¡£¡£¡£¡£¡£¡£

3-²¼Âå·ÒµÄ»¯Ñ§ºÏ³É.jpg

²¼Âå·ÒµÄ»¯Ñ§ºÏ³É[2]

2009Ä꣬£¬£¬£¬Florida State University µÄAndrew?R. BogdanµÈÈËʹÓÃ΢ÐÍ·´Ó¦Æ÷ºÏ³É²¼Âå·Ò¡£¡£¡£¡£¡£¡£Î¢ÐÍ·´Ó¦Æ÷ÊÇÔÚ΢ͨµÀ»òÕ­¿×¹ÜÖоÙÐиüÇå¾²¡¢¸ü¸ßЧ¡¢¸ü¾ßÑ¡ÔñÐԵĻ¯Ñ§×ª»¯¡£¡£¡£¡£¡£¡£Ê¹ÓÃÒì¶¡»ù±½ºÍ±ûËáΪÖÊÁÏ£¬£¬£¬£¬·´Ó¦×Üʱ¼äԼΪ10·ÖÖÓ£¬£¬£¬£¬´Ö²úÂÊΪ 68%£¬£¬£¬£¬Öؽᾧºó²úÂÊΪ 51% (ͨ¹ý GC ºÍ NMR ÆÊÎö´¿¶ÈΪ 99%)¡£¡£¡£¡£¡£¡£

4-²¼Âå·ÒÒ»Á¬ºÏ³É¹¤ÒÕ.jpg

²¼Âå·ÒÒ»Á¬ºÏ³É¹¤ÒÕ[3]

2014Ä꣬£¬£¬£¬Massachusetts Institute of Technology (MIT)µÄDavid R. Snead, ²©Ê¿ºÍTimothy F. Jamison½ÌÊÚÒÔÒì¶¡±½ºÍ±ûõ£ÂÈΪÖÊÁÏ£¬£¬£¬£¬¾ÙÐжಽһÁ¬»¯·´Ó¦¡£¡£¡£¡£¡£¡£´ÓÆðÊ¼Ô­ÍÆ²â»ñµÃÄ¿µÄ»¯ºÏÎ£¬£¬£¬ÔÚÈý·ÖÖÓµÄ×Üʱ¼äÄÚ£¬£¬£¬£¬²¼Âå·Ò´ÓÆä»ù±¾½á¹¹µ¥Î»×é×°¶ø³É£¬£¬£¬£¬Ã¿Ò»²½µÄƽ¾ù²úÂÊÁè¼Ý 90%¡£¡£¡£¡£¡£¡£

5-²¼Âå·ÒÒ»Á¬ºÏ³É¹¤ÒÕ.jpg

²¼Âå·ÒÒ»Á¬ºÏ³É¹¤ÒÕ[4]

²Î¿¼ÎÄÏ×

[1] Ashish Singh, et al. Neuroinflammatory responses in Parkinson's disease: relevance of Ibuprofen in therapeutics. Inflammopharmacology. 2021 Feb;29(1):5-14. doi: 10.1007/s10787-020-00764-w.

[2] Mark A. Murphy. Early Industrial Roots of Green Chemistry and the history of the BHC Ibuprofen process invention and its Quality connection. Foundations of Chemistry volume 20, pages121¨C165 (2018).

[3]Andrew R Bogdan, et al.  The continuous-flow synthesis of Ibuprofen. Angew Chem Int Ed Engl. 2009;48(45):8547-50. doi: 10.1002/anie.200903055.

[4] David R Snead , et al. A three-minute synthesis and purification of ibuprofen: pushing the limits of continuous-flow processing. Angew Chem Int Ed Engl. 2015 Jan 12;54(3):983-7. doi:

Ïà¹ØÐÂÎÅ
»¯Ñ§ºÏ³É¶àëÄÒ©Îï
2015-08-05
»¯Ñ§ºÏ³É¶àëÄÒ©ÎïÊÇÖ¸½ÓÄÉ»¯Ñ§ºÏ³ÉÒªÁìÖÆ±¸µÄ¶àëÄÀàÒ©Îï¡£¡£¡£¡£¡£¡£ÕâÀàÒ©ÎïµÄҩѧÑо¿Í¬Ñù×ñÕÕ¹ú¼ÒʳÎïÒ©Æ·¼àÊÓ¹ÜÀí¾ÖÒѾ­Ðû²¼µÄÏà¹Ø¼¼ÊõÖ¸µ¼Ô­ÔòµÄÒ»Ñùƽ³£ÐÔÒªÇ󡣡£¡£¡£¡£¡£
ͨÍù¿¹Ð¹ڵÄÌØÐ§º½µÀ¡ª¡ªÅÁÂÞΤµÂ
2022-04-22
ÒßÃçµÄ¿ìËÙ¿ª·¢¹ØÓÚÒ»Á¬µÄ¿¹Ð¹ڲ¡¶¾ÖÁ¹ØÖ÷Òª¡£¡£¡£¡£¡£¡£È»¶øÌôÕ½Ò²Ò»Ö±±£´æ£¬£¬£¬£¬ºÃ±ÈбäÌåµÄÒ»Ö±·ºÆð¡£¡£¡£¡£¡£¡£Òò´Ë£¬£¬£¬£¬¿ª·¢¿¹²¡¶¾ÁÆ·¨Ò²ÊÇÓ¦¶Ô COVID-19 Ò»Á¬ÍþвµÄÖ÷ÒªÒªÁì¡£¡£¡£¡£¡£¡£
¸èÀñÊÚȨ»ÔÈðÖйúйÚÒ©ÎïPaxlovidØ­¡°ÃÀ¡±ÌìÐÂÒ©ÊÂ
2022-10-28
10ÔÂ28ÈÕ£¬£¬£¬£¬¸èÀñÖÆÒ©Ðû²¼Í¨¸æ£¬£¬£¬£¬Ðû²¼Æä×Ó¹«Ë¾ÒÑÓë»ÔÈðÖйú¾ÍÀûÍÐÄÇΤ100ºÁ¿Ë±¡Ä¤ÒÂÆ¬Ç©ÊðÊÚȨÓ빩ӦЭÒé¡£¡£¡£¡£¡£¡£Æ¾Ö¤Ð­Ò飬£¬£¬£¬¸èÀñ½«·ÇÅÅËûÐÔµØÊÚȨ»ÔÈðÖйúÔÚÖйú´ó½ʹÓøèÀñµÄÀûÍÐÄÇΤƬ²¿·Ö×¢²á×ÊÁÏÓÃÓÚйÚÒ©ÎïPaxlovid£¬£¬£¬£¬²¢Îª»ÔÈðÖйúÔÚÖйú´ó½Éú²úºÍ¹©Ó¦ÀûÍÐÄÇΤƬ£¬£¬£¬£¬ÒԻݼ°Öйú´ó½µÄ»¼Õß¡£¡£¡£¡£¡£¡£
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿